High response rates with single-agent belantamab mafodotin in relapsed systemic AL amyloidosis

Affiliations

• ¹ Department of Haematology, University College London Hospital, London, UK.
• ² National Amyloidosis Centre, University College London (Royal Free Campus), London, UK.
• ³ Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology, London, UK.
• ⁴ Department of Haematology, University Hospital of Wales, Cardiff, UK.
• ⁵ Department of Internal Medicine, Nephrology and Transplantation Medicine, Central Clinical Hospital of the Ministry of Internal Affairs, Warsaw, Poland.
• ⁶ Department of Hematology, Transplantation and Internal Medicine, Medical University of Warsaw, Warsaw, Poland.
• ⁷ National Amyloidosis Centre, University College London (Royal Free Campus), London, UK. a.wechalekar@ucl.ac.uk.